In conclusion, these findings provide support for the notion that DLGAP1‐AS1 plays an oncogenic part in HCC by acting as a sponge to modulate miR‐486‐5p/H3F3B axis and represents huge potential to serve as a prognostic biomarker and therapeutic target in HCC.132. This evidence concerns the gene DLGAP1 and hepatocellular carcinoma.